Word: teste
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...guest when trying to get baby on board. Murkoff devotes an entire page to other acronyms, alphabetized and far more obscure: If BD is baby dance, a.k.a. sex, then DP translates as dancing partner. There's also BFN (big fat negative) and BFP (big fat positive) to describe pregnancy-test results, natch. And don't forget the appropriate salutation or, as the case may be, sign-off: FTTA (fertile thoughts...
...have occurred in February). So far, no pigs have been found to be infected with the virus, other than at one farm in Canada on May 2, where the swine were actually infected by a human worker. And on May 14, Smithfield announced that Mexican authorities had completed tests of the company's pigs in Perote and found no evidence of the virus in the swine. (It's not clear what test Mexican authorities used; only blood tests for antibodies can confirm the virus...
Kerr looked at the usefulness of the test in more than 1,000 Stage 2 colon-cancer patients. At this stage, the cancer has penetrated the colon wall but has not spread beyond the colon into the lymph nodes or nearby tissues. About 90% of Stage 2 patients survive five years beyond the diagnosis. In almost all cases, surgeons remove the cancer first; studies have shown that surgery alone can cure four out of five cases of Stage 2 colon cancer. But how do patients know if they are the outlying fifth case or if they are among the fortunate...
With the new screening test, however, doctors can now potentially spare some patients chemotherapy and exposure to its often toxic side effects. Genomic Health, a biotechnology company, is hoping to launch the test commercially in 2010. The company isn't new to the field of cancer predictors: in 2007 it released the first test of this kind to predict the recurrence of breast cancer. That screen, known as Oncotype Dx, is used widely today and relies on a 21-gene assay to tell patients how likely their cancer is to recur and whether their tumors will respond to chemotherapy...
...latter capability is something the colon-cancer screen doesn't have - yet. But it's something that Dr. Leonard Saltz, a colon-cancer expert at Memorial Sloan Kettering Cancer Center, believes is necessary to make the test truly useful for doctors and patients. "What this test clearly does is tell people that you have a greater likelihood of being in the group that is at high risk or low risk of having a recurrence, but it doesn't tell you that your risk will change if you get chemo...